An Overview of Currently Available Injectable Therapies in Diabetes: A Guide to Practitioners

Area of Science:

• Endocrinology
• Pharmacology
• Internal Medicine

Background:

• Diabetes mellitus is a prevalent chronic condition requiring diverse management strategies.
• Injectable therapies are crucial for diabetes care, yet terminology and practice variations cause confusion.
• Healthcare professionals need clear guidance on the evolving landscape of diabetes injectables.

Purpose of the Study:

• To provide a comprehensive overview of current injectable therapies for diabetes management.
• To clarify the types, mechanisms of action, and clinical applications of insulin and non-insulin injectables.
• To assist healthcare providers in making informed decisions for optimizing patient outcomes.

Main Methods:

• Extensive literature review focusing on injectable diabetes treatments.
• Analysis of insulin formulations (short-, intermediate-, long-acting) and their variations.
• Examination of non-insulin injectables including GLP-1 receptor agonists, dual GLP-1/GIP agonists, amylin analogs, and co-formulations.

Main Results:

• Insulin therapies provide individualized glycemic control.
• Non-insulin injectables offer benefits such as weight management and reduced hypoglycemia risk.
• The review includes both innovator products and biosimilars for a complete understanding.

Conclusions:

• A clear understanding of injectable diabetes therapies is essential for effective patient care.
• This review serves as a guide to navigate the complexities of insulin and non-insulin injectable options.
• Informed decision-making regarding injectable treatments can optimize therapeutic outcomes in diabetes management.